Patents by Inventor Revital LEVY

Revital LEVY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated peptides derived from the B7 ligand dimer interface and uses thereof
    Patent number: 11613565
    Abstract: Disclosed are peptides comprising amino acid residues of the dimer interface of human B7-1 and B7-2 and compositions and uses thereof.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: March 28, 2023
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
    Inventors: Raymond Kaempfer, Revital Levy
  • ISOLATED PEPTIDES DERlVED FROM THE B7 LlGAND DlMER INTERFACE AND USES THEREOF
    Publication number: 20200148741
    Abstract: Disclosed are peptides comprising amino acid residues of the dimer interface of human B7-1 and B7-2 and compositions and uses thereof.
    Type: Application
    Filed: January 21, 2020
    Publication date: May 14, 2020
    Inventors: Raymond KAEMPFER, Revital LEVY
  • Isolated peptides derived from the B7 ligand dimer interface and uses thereof
    Patent number: 10584157
    Abstract: Disclosed are peptides comprising amino acid residues of the dimer interface of human B7-1 and B7-2 and compositions and uses thereof.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: March 10, 2020
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
    Inventors: Raymond Kaempfer, Revital Levy
  • ISOLATED PEPTIDES DERlVED FROM THE B7 LlGAND DlMER INTERFACE AND USES THEREOF
    Publication number: 20180044400
    Abstract: Disclosed are peptides comprising amino acid residues of the dimer interface of human B7-1 and B7-2 and compositions and uses thereof.
    Type: Application
    Filed: March 16, 2016
    Publication date: February 15, 2018
    Inventors: Raymond KAEMPFER, Revital LEVY